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Abstract 
Bacterial biofilms are communities of bacteria which grow on various surfaces.  They are 
composed of the bacteria themselves and an extracellular polymeric slime (EPS) matrix which 
they encase themselves within.  Biofilms can be found in any environment where there is 
persistent water, such as oceans, pipes, and the human body.  Biofilms are formed when free-
floating, planktonic bacteria attach to a surface and grow.  Cells in a biofilm use 
communication via cell signaling bacteria to coordinate the behavior of the whole biofilm 
population for a diverse array of functions, including expression of virulence factors, 
proliferation and dispersal.  In cell signaling, diffusible chemicals are released by individual 
bacteria which can be “sensed” by others in the biofilm.  
A short-range cell signaling protein in Myxococcus was discovered to be responsible for social 
motility in biofilms.  We have identified a single potential protein homolog in Pseudomonas 
aeruginosa, PA4079, for which we are testing to determine social motility differences between a 
wild-type strain of P. aeruginosa versus a strain with a knockout of the PA4079 gene.  Biofilms 
of both a wild-type strain tagged with green fluorescent protein (GFP) and a PA4079 transposon 
knockout strain tagged with GFP are grown under various media and temperature conditions.  
Images have been collected to compare phenotypic differences among the biofilms.  In current 
experiments, we are using time-lapse photography to determine if dispersal rates and motility are 
affected by the absence of this protein.  We are also utilizing a flow cell system to manipulate 
biofilms under shear stress.  
We believe the PA4079 gene and homologs may be responsible for dispersal from pathogenic 
biofilms and could represent a possible target for treating problematic biofilm infections.  With 
!  ii
the information provided from this research, we will be able to better understand social motility 
and cell-signaling of Pseudomonas aeruginosa.  Our results could bring forth new ways to treat 
and prevent pathogenic biofilms within orthopedic environments (i.e implants, reparative 
surgeries) as well as natural environments.  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1. Introduction 
 Bacterial biofilms are a leading concern in both the medical and environmental sciences.  
Biofilm formation, although known, is difficult to understand and diagnose which can lead to 
pathogenic bacterial infections.  Planktonic cells adhere to any surface with consistent access to 
water, where they will grow and divide.  These sessile bacterial communities encase themselves 
in a slime matrix composed of various extracellular polymeric substances (EPS) including 
polysaccharides, proteins, and DNA, providing them safety through structural durability and 
antibiotic resistance, where they will continue to grow and disperse throughout their 
environment.¹  Dispersal of biofilms in the body leads millions of people to experience chronic 
infections yearly (Figure 1).²  Pseudomonas aeruginosa infections are most commonly found on 
catheters, wounds, contact lenses, implants, and also in cystic fibrosis patients as a non-surface-
related infection.¹   
 
Figure 1²: Biofilm life cycle of Pseudomonas aeruginosa. Stage I: planktonic bacteria attach to an abiotic surface. 
Stage II: irreversible adherence of planktonic bacteria. Stage III: microcolony formation. Stage IV: biofilm 
maturation and growth of 3-D community. Stage V: dispersal of planktonic bacteria to other sites. Biofilm can 
adhere to biological and non-biological surfaces, and disperse throughout the body creating a chronic infection. 
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 A short-range intercellular signaling protein was discovered in Myxococcus xanthus 
which was necessary for sporulation, gene expression, and cell motility.  Termed C-factor, this 
protein was discovered by Seung K. Kim and Dale Kaiser in 1990.³  It was seen that cell motility 
was a necessity for proper transmission of C-factor, and observations suggested that movement 
allowed cells to establish “spacial patterns” necessary for C-factor-dependent sporulation and 
gene expression.  This spacial pattern caused M. xanthus cells to settle in the grooves of 
sandpaper-scored developmental surfaces with their long axes parallel to the grooves.³   
 In previous biofilm studies (Purevdorj-Gage et al, 2005), it was seen that Pseudomonas 
aeruginosa PAO1 biofilms form fruiting bodies within which cells differentiate into a planktonic 
phenotype, then disperse and swim into surrounding fluid. Upon dispersal, cells leave behind 
hollow mounds within the biofilm which do not exhibit further expansion or refill with new cell 
growth.⁴  It was seen that a “critical cell cluster diameter of 100 µL” was necessary for swarming 
phenotypes to be seen.⁴  This phenotypic differentiation suggested a regulated behavior/quorum 
sensing cell signal mechanism, for which a solid agar assay was developed (after Kim and  
Kaiser, 1990) by which the swarming phenotype could be initiated by growth on roughened agar, 
since swarming does not occur on conventional smooth agar.  Results of this assay were seen to 
mirror the Kim and Kaiser results (1990), fueling further hypotheses regarding the C-factor.  
 From this analysis, a single potential C-factor homolog, which we have labeled PA4079, 
was identified in the PAO1 genome.  This homolog had 50% amino acid identity to the C-factor 
of M. xanthus, and when compared to other C-factor homologs using Clustal W (http://
www.ebi.ac.uk/clustalw/) this homolog was clustered with other biofilm-forming bacteria that 
exhibit social behavior, including M. xanthus.  These clustered organisms also showed motility 
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through twitching, swimming, and swarming, which supported the hypothesis that the PA4079 
gene and homologs may be responsible for dispersal from P. aeruginosa biofilms and could 
potentially represent a target for treating and preventing biofilm-related infections. 
 Assays were conducted previous to this investigation by Heather Eggleston to test for 
swimming, swarming, and twitching motilities between P. aeruginosa PAO1 (wild-type) and two 
mutants: one containing a transposon deletion and the other containing a clean deletion of the 
PA4079 gene.  For twitching motility, bacteria were inoculated in the center of solid LB agar.  
For swimming motility, bacteria were inoculated in the center of LB, 0.2% agar plates.  For 
swarming motility, bacteria were inoculated in the center of LB,1.5% agar plates.  1.5% agar is 
the standard for solidifying media for swarming motility assays.⁵  All plates were incubated and 
grown for 4 days, and imaging was done daily to track the maximum motility zones for each test.  
Results in Figure 2 show that both mutant strains show higher levels of twitching (A), swimming 
(B), and swarming (C) motility when compared to the wild-type. 
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 Figure 2: Motility Assay Results. A, B) Both PA4079 and CMS3858 mutants showed more twitching/
swimming motility than wild-type PAO1. C) More swarming motility was observed in both mutants, but 
no observable difference was noticed between mutant isolates.  
 The main aims of this investigation were to determine if social motility differences exist 
between a wild-type strain of P. aeruginosa when compared to strains lacking the PA4079 gene, 
and if the gene influences how biofilms phenotypically formed when influenced by various 
environmental conditions.  The goal was confirm that PA4079 does affect motility rates within P. 
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aeruginosa biofilms.  With the information provided from this research, we can better understand 
the social motility and cell-signaling of Pseudomonas aeruginosa.  Our results could bring forth 
new ways to treat and prevent pathogenic biofilms within orthopedic environments (i.e implants, 
reparative surgeries) as well as natural environments. 
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2. Materials and Methods 
2.1 Growth Curves for Strains 
 In order to investigate phenotypic differences involving growth rates and dispersal within 
biofilms, more information was needed to determine how each mutant isolate grew when 
compared to the wild-type.  Isolates listed in Table 1 were provided by the University of 
Washington Genome Center (UWGC), including the wild-type strain PAO1, a mutant with a  
PA4079 gene knockout, a mutant with a clean deletion of the PA4079 gene, and each strain 
tagged with green fluorescent protein (GFP).  Isolates listed in Table 2 were provided by Dr. 
Robert Shanks of the University of Pittsburgh, Department of Ophthalmology, including a 
mutant with a gene deletion for the SocA gene and manipulations of the CMS3858 mutant to 
reintroduce the PA4079 gene restore expression of the wild-type phenotype.  Glycerol stocks 
were created for all acquired strains and stored at -80℃ until needed for experiments. 
 For each isolate, 5 mL Lysogeny Broth (LB) broth or LB supplemented with gentamicin 
(30 µg/mL) was inoculated to grow liquid cultures overnight at 37℃.  5 µL culture was diluted 
in 5 mL fresh media, then the dilutions were dispensed in 200 µL increments into a BD Falcon 
96-well polystyrene plate (Image 1) in four replicates.  24-hour kinetic reads were taken using a 
spectrophotometer set to OD₆₀₀ at 37℃.  For all initial dilutions per strain, serial dilutions were 
conducted at the initial (0-hour) and 24-hour time points to calculate CFU/mL for each strain to 
determine if strains grow at similar rates in under the same conditions (Table 1A).  
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Table 1: Isolates acquired from the University of Washington Genome Center. 
 * Isolates were tagged with GFP via plasmid (from Dr. Mike Franklin, Montana State University)        
    in our laboratory. 
Table 2: Isolates acquired from Dr. Robert Shanks, used only in crystal violet assay. 
  ** Isolates require 30 µg/mL gentamicin in media for growth. 
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Strain # Description Notes
CMS4202 PAO1 ΔPA2931 PAO1 with SocA gene deletion
CMS4292 ** PAO1 ΔPA079 + pMQ132 CMS3838 + empty plasmid (control)
CMS4293 ** PAO1 ΔPA079 + pMQ539 Gene compliment to restore WT 
function 
CMS3858 + pMQ132 + PA4079
CMS3960 ** PAO1 ΔPA079 + pMQ400 
(tdtomato)
CMS3858 tagged with RFP isolated 
from tomato
Strain # Description Notes
PAO1 PAO1 (WT) Wild-Type
PA4079 PAO1 ΔPA079 PAO1 with PA4079 gene knockout
CMS3858 PAO1 ΔPA079 PAO1 with a clean deletion of 
PA4079
PAO1 + pMRP9* PAO1 + pMRP9 PAO1 tagged with GFP
PA4079 + 
pMRP9*
PAO1 ΔPA079 + pMRP9 PA4079 tagged with GFP
CMS3858 + 
pMRP9*
PAO1 ΔPA079 + pMRP9 CMS3858 tagged with GFP
  
 
 
 
Figure 3: Growth curves for both all strains at 37℃ show no significant differences in growth rates between initially 
acquired strains with temperature changes. Mutations do not appear cause a difference in growth rate. Error bars 
calculated using standard deviation calculations. 
2.2 Crystal Violet Assay 
 A crystal violet assay was conducted to get quantifiable data for the amount of biomass 
produced by each strain over time.  Isolates from Tables 1 and 2 were grown in LB broth or LB 
broth supplemented with 30 µg/mL gentamicin, depending on the required growth conditions of 
each isolate, overnight at 37℃.  Cultures were plated in 2 Costar 96-well non-coated polystyrene 
plates, one for Day 3 tests and one for Day 5 tests, and in 35 mm polystyrene petri dishes for use 
with confocal microscopy.  Established biofilms were rinsed with 10 mL sterile phosphate-
buffered saline (PBS) solution (Thermo Fisher) daily before adding fresh media.  On days 3 and 
5 for respective biofilm growth, 180 µL of spent media and planktonic cells were removed from 
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each well of the 96-well plate. Biofilms were rinsed once with 180 µL sterile PBS solution, 
inverted, and tapped dry on filter paper.  200 µL of 0.1% crystal violet staining solution (from 
1% stock in distilled water) were added per well, then incubated at room temperature for 15 
minutes before being inverted and tapped dry on filter paper.  Wells were rinsed with 200 µL 
sterile PBS solution to remove excess crystal violet solution and inverted to remove sterile PBS.  
200 µL of 95% EtOH solution was added per well and allowed to incubate on the bench at room 
temperature for 10 minutes. After incubation period, absorbance readings were taken at OD₅₇₀ 
and OB₅₉₅ to compare biofilm formation (Figure 4B) 
 
Figure 4: Crystal violet assay plate, A) pre-readings, B) post-readings. Cultures plated in triplicate. 1: WT PAO1, 2: 
PA4079, 3: CMS3858, 4: CMS4202, 5: CMS4292, 6: CMS4203, 7: CMS3960. 
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2.3 Biofilm Production - Static Growth 
 For all biofilm experiments, only isolates tagged with GFP were used to visualize 
differences between the strains; biofilms were counterstained with propidium iodide to compare 
live/dead cells before imaging.  Propidium iodide (PI) was chosen as a counterstain for these 
biofilms because it will only permeate the cell membrane of dead cells, therefore live cells 
appeared bright green and dead red under GFP and RFP filters respectively.  To understand how 
to build, establish, and properly image biofilms, static biofilms were grown in 35 mm MatTek 
glass-bottomed microwell dishes (14 mm microwell). Glass-bottomed dishes were chosen for 
experimental purposes, although P. aeruginosa has been seen to establish better adherence to 
hydrophobic materials like coated polystyrene, so biofilm progression could be visualized and  
captured.⁶ʹ⁷   
2.3.1 Temperature Variation 
 Biofilms were grown at two temperatures, 37℃ and 22℃, to determine if temperature 
difference influenced rate of establishment and phenotypic expression of cells within the 
biofilms.  Trials were conducted for 5 days at each temperature. MatTek dishes were set up for 
PAO1, PA4079, and CMS3858 in two replicates, with 30 µL liquid culture in 3 mL LB broth per 
dish.  Established biofilms were rinsed with 10 mL sterile PBS solution daily before the addition 
of 2 µL PI and imaged.  3 mL fresh media was added per dish before being returned to proper 
incubator overnight.  
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2.3.2 Media Variation 
 Biofilms were also grown in M9 minimal media supplemented with 2% glucose to 
determine if nutrition played a role in biofilm establishment and phenotypic expression of P. 
aeruginosa.  MatTek dishes were set up for PAO1, PA4079, and CMS3858 in duplicate with 
same procedures used for temperature variation experiments.  Biofilms  were grown at both 37℃ 
 and 22℃ for a total of 7 days.   
2.4 Biofilm Production - Flow Cell System 
 Biofilms were grown using a flow cell system to determine if these mutants establish 
biofilms under dynamic conditions, and how the cells behave within biofilms when experiencing 
hydrodynamic flow conditions.  Flow cell systems allow biofilms to grow and mature as 
planktonic cells are removed by the flow of fresh media.⁸  Using the flow cell system not only 
allows for the in vitro cultivation and evaluation of P. aeruginosa biofilms, but also provides a 
way to non-invasively observe the growth,  
physiology, and structure of the bacteria when paired with microscopy.⁸’⁹ 
2.4.1 Construction and Assembly 
 Flow cell systems used for the following experiments were constructed using a metal 
flow cell (Biosurface Technologies Corporation) with a mounted microscope slide holding 4 
borosilicate microglass cells, each 1.00MM I.D. x 0.15MM Wall x 50 Length, (Friedrich & 
Dimmock, Inc.) as seen in Figure 5.  
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 Figure 5: Image of flow cell cassette used in each biofilm experiment. Numbers 1-4 on left side refer to lines 
coming from bubble trap and multi-channel pump. Strain numbers on right side indicate which strain type is 
growing in which lines, also showing that all trials run with this flow cell were done in duplicate for each strain. 
Each glass cell measures 10 cm long. Size 13 silicone tubing attaches directly to the inlet and outlet of each cell as 
shown, where it is attached to an additional 50 cm of size 13 tubing after and before inoculation and collection ports 
respectively. 
 Systems were comprised of an autoclavable inlet media vessel (Nalgene Company) 
holding appropriate sterile media for each trial of biofilms grown, glass windows and condensers 
to monitor flow rate and check for contamination, plastic and stainless steel line clamps to 
prevent contamination during inoculation, a high-precision multichannel pump (Ismatec) to drive 
the flow of the medium through the system, bubble traps, rubber inoculation and collection ports, 
the flow cell cassette (Figure 5) within which the biofilms are cultivated and subsequently 
viewed,  and an outlet waste container (Nalgene Company).  These individual components were 
connected by peroxide-cured silicone tubing (Masterflex) and various plastic and T- connectors 
(Cole Parmer).  All tubing from the inlet media vessel before the pump and after the collection 
ports to the outlet waste container was size 16 Masterflex tubing, ID 3.1 mm.  At the 
multichannel pump smaller Masterflex tubing, ID 0.8 mm, was substituted to connect the bubble 
trap, rubber ports, and flow cell (Figure 6).   
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A) 
B) 
Figure 6: A) Schematic diagram of a flow cell system including: a. medium container, b. multichannel pump. c. 
syringe bubble trap; d. flow cell; e. waste container connected using silicone tubing providing a closed system. 
Arrows represent the direction of flow. B) Aerial view of actual flow cell setup used for experiments. a: media tank, 
b: glass windows and condenser, c: multichannel pump, d: syringe bubble trap, e: plastic/stainless steel line clamps, 
f: rubber ports, g: flow cell, h: waste container. 
 Precautions were taken to minimize air bubbles from forming within the system and 
disturbing the biofilms.  These precautions included sealing around tubing at the inlet medium 
vessel with silicone caulking to make sure it was airtight, fitting the vessel with a venting 
apparatus filled with glass wool for exhaust, the use of an elevated back flow-preventing 
condenser before the pump to draw air bubbles out of solution by reducing the negative pressure 
gradient within the tubing, and the use of a bubble trap made up of sterile 5 mL Luer-Lok tip 
syringes (Becton Dickinson) and plastic stopcocks to capture any remaining air bubbles 
downstream from the multichannel pump before they could enter the flow cell cassette (Figure 
7). 
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a
c
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  Once assembled, liquid media for the current experiment was mixed in the inlet media 
vessel before the entire system was autoclaved for sterilization (121℃, 55 minutes) with all line 
clamps open.  Upon removal from the autoclave, the inlet media container was connected to the 
rest of the silicone tubing under sterile conditions, all line clamps were closed, and stopcocks 
were added to the syringe tips.  The system was allowed to cool to room temperature overnight 
to check for contamination, then clamps were opened as the pump was run at maximum speed to 
saturate the tubing for inoculation.  Saturating the tubing allowed us to check for leaks and/or 
blockage within the system the following day.  At this time, the pump was calibrated to flow at a 
rate of 100 µL/min, 0.51 rpm.  If an experiment was to be conducted at 37℃, the entire system 
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Figure 7: Bubble trap setup for dynamic growth biofilm experiments. Incorporation of the bubble trap 
downstream from the multi-channel pump prevented air bubbles introduced into the media from 
destroying biofilm growth in the flow cell. 
would be placed in a large incubator after tubing was saturated and checked while in the 
incubator for leaks; if experiment was to be conducted at room temperature, approximately 22℃, 
the system would remain on a cart within the  laboratory area for the  
duration of the trial. 
2.4.2 Process for System Inoculation/ Extraction of Effluent 
 For all flow cell experiments, the two strains of P. aeruginosa used were PAO1 (wild-
type) and the CMS3858 mutant (clean deletion of PA4079 gene).  Liquid cultures  for each strain 
were grown overnight in the proper media for the trial at 37℃.  A 10⁻² dilution was prepared 
with fresh media for all overnight liquid cultures prior to inoculation.  Before inoculating flow 
cell system, tubing was clamped off roughly 15 cm upstream the flow cell cassette using the 
stainless steel clamps seen in Figure 6 (label e).  Inoculation ports were sterilized with 70% 
EtOH solution before each inoculation.  Using sterile 5 mL Luer-Lok tip syringes (Becton 
Dickinson) and 22 gauge 1½ inch needles (Becton Dickinson) seen in Figure 8A, lines 1 &  2 
were inoculated with 5 mL of the wild-type PAO1 dilution and lines 3 & 4 were inoculated with 
5 mL of CMS3858 dilution.  The system was seeded at a rate of 20 drops per minute to prevent 
cell lysis or disruption of previously-seeded lines.  Figure 8B shows how inoculations were 
carefully conducted to not create air bubbles within the system.  Lines were left clamped shut 
overnight to allow bacterial cells to adhere within the glass cells, then lines were unclamped and 
media flow was initiated the following day. 
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 Figure 8: Inoculation of the flow cell. Before inoculating, tubing was clamped 10 cm upstream of the flow cell, 
plastic line clamps upstream the multi-channel pump were clamped as another level protection from contamination. 
A) The flow cell system was inoculated using a sterile 5 ml syringe and accompanying 22 gauge 1 ½ inch needle 
(Becton Dickinson). B) The inoculation port was filled with 70% EtOH solution, pierced through the center until the 
needle was visibly within the y-shaped junction, then 5 mL inoculum was seeded into the line at 20 drops per minute 
to prevent disruption of previously-seeded lines. 
 Once inoculated, 200 µL of each inoculum was placed in the first wells of a 96-well 
polystyrene plate (Falcon) for serial dilution and enumeration to calculate how many CFU/mL 
were in the inocula.  Inoculum was diluted (20 µL into 180 µL LB broth) to a dilution factor of 
10⁻⁸ down the corresponding column in the plate, then 10 µL (4 sets of 2.5 µL) were spotted on 
LB agar before placed in a 37℃ incubator for enumeration the following day.  Daily extractions 
of effluent followed the same process for serial dilution and enumeration, where 200 µL effluent 
was slowly drawn from each line from the rubber collection ports sterilized with 70% EtOH 
using 1 mL tuberculin slip-tip syringes (Becton Dickinson), seen in Figure 9A.  Effluent was 
placed into the first wells of the 96-well plate and serial dilution and enumeration was conducted 
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A)            B) 
as with inoculation.  Extractions, serial dilutions and enumerations were completed daily for 
each line during each experiment to ensure biofilms were growing at proper rates and confirm no 
contamination had occurred within the lines. 
2.4.3 Temperature Variation 
Figure 9: Procedure for Drawing Effluent. Effluent draws were conducted daily before imaging to calculate CFU 
counts and ensure biofilms were growing as expected. A) Effluent was drawn using a sterile 1 ml syringe and 
accompanying 22 gauge 1 ½ inch needle (Becton Dickinson). B) As with inoculation, the collection port was filled 
with 70% EtOH solution, pierced through the center until the needle was visibly within the y-shaped junction, then 
200 µL inoculum was drawn off slowly per line to prevent disrupting  
other biofilms. Process was repeated for each line. 
 As with the static growth experiments conducted in MatTek dishes, biofilms were grown 
at two temperatures, 37℃ and 22℃, to determine if temperature difference influenced rate of 
establishment and phenotypic expression of cells within the biofilms during dynamic growth.  
Trials were conducted for 5 days for both 37℃ and 22℃.  For the 37℃ growth experiment, the  
system only left the incubator when lines were being imaged for observation. 
!  17
A)           B) 
2.4.4 Media Variation 
 Similar to the static growth experiments conducted in MatTek dishes, biofilms were 
grown using either full-strength LB broth (25g LB broth miller per 1L dH₂O) or 1/10x strength 
LB broth (2.5g LB broth miller per 1 L dH₂O) to determine if starvation and nutrient levels play 
a role in biofilm establishment and phenotypic expression of P. aeruginosa.  MatTek dishes were 
set up for PAO1, PA4079, and CMS3858 in duplicate with same procedures used for temperature 
variation experiments.  Biofilms were grown in both media types at 22℃ for 5 days, and for full 
strength LB broth at 37℃ for a total of 5 days.  
2.4.5 Disassembly and Cleaning 
 At the conclusion of each experimental trial, established biofilms were flushed out of the 
glass cells and tubing before the next system was ready to be set up and autoclaved.  The inlet 
media vessel was clamped off, and another piece of connected tubing was opened and set up for 
bactericidal solutions.  50% bleach solution was run through the system at maximum pump 
speed for approximately 30 minutes, then 70% EtOH solution was substituted in and run through 
for 15 minutes.  Tubing was detached, discarded, and replaced after each trial as needed.  
Downstream effluent tubing was flushed with UltraPure DNAse/RNAse-free distilled water 
(Thermo Fisher) at maximum pump speed and massaged as needed to dislodge any remaining 
adherent biofilm waste matter.  The flow cell was carefully opened and the glass microscope 
slide was removed from the flow cell base along with any cracked or broken glass cells.  Once 
the entire system was checked over to ensure no leaks were imminent, the waste container then 
received 1 L of 50% bleach solution and was allowed to destroy any living bacteria overnight.  
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The following day, all liquid was pumped out of the system at maximum pump speed, waste 
vessel contents were autoclaved and disposed of in the proper biohazard waste container, and the 
media and waste vessels were thoroughly washed before reassembly; the system was then  
autoclaved and recycled for the next experiment. 
2.5 Pyocyanin Assays 
 P. aeruginosa is known to produce the distinctive blue pigment pyocyanin, which 
appeared to be hyper-expressed within the mutant isolates when grown on solid LB agar or in LB 
broth.  Our group was interested to see if pyocyanin production levels had correlational value to 
the presence or absence of the C-factor.  Previously, P. aeruginosa has been seen to not produce 
pyocyanin if grown in culture media containing >1% glucose in solution, even in medias 
supplemented with blood or veal infusions.¹⁰	 
 All strains used in pyocyanin pigment assays were not tagged with GFP to prevent 
mistaking pyocyanin production and fluorescence for GFP.  Various tests were set up and 
conducted to determine whether or not the increase in pigment could be contributed to the loss of 
the PA4079 gene.  Initial assays using LB broth and agar plates were conducted to get a basic 
understanding of how much pyocyanin was being produced by the wild-type PAO1 and two 
mutant strains.  Liquid cultures for PAO1, PA4079, and CMS3858 were grown in 5 mL LB broth 
overnight at 37℃.  Photographs were taken of all liquid cultures for visual comparison of 
pyocyanin production (Figure 10A). 
 In assay 1, 1 mL of each liquid culture was deposited into labeled 1.5 mL microcentrifuge 
tubes before being spun down at maximum speed for 1 minute.  1.5 mL of each liquid culture 
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was deposited into cuvettes before imaging for visual comparison of the supernatant pigment 
(Figure 10B).  100 µL of supernatant was then placed into the wells of a 96-well microtitre plate, 
then placed in a GelDoc UV gel documentation system to get an image of the pyocyanin 
fluorescence (Figure 10C). 
 
 
 
 
Figure 10: Pyocyanin Production. 1: WT PAO1, 2: PA4069, 3: CMS3858, B: Blank LB broth for control. 
A) Liquid cultures immediately after removal from incubator. B) Cuvettes containing 1.5 mL liquid cultures. C) 
GelDoc image of supernatant pyocyanin fluorescence analyzed with FIJI. D) WT PAO1 post-centrifugation. Can 
distinguish pyocyanin in supernatant (green) from cell pellicle (pink/tan). 
 For assay 2, Pseudomonas isolation broth and Jensen’s media were made to determine if 
nutrition could influence pyocyanin production.  Liquid cultures for PAO1, PA4079, and 
CMS3858 were grown in 5 mL of each media (6 liquid cultures total) overnight at 37℃.  The 
following day, 1 mL per liquid culture was deposited into individually-labeled 1.5 mL 
microcentrifuge tubes before being spun down at maximum speed for 1 minute.  Like in assay 1, 
100 µL of supernatant was drawn off from each spun-down culture, then placed in a black-
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walled 96-well plate to take absorbance readings. Images were once again taken using the 
GelDoc system as in assay 1. 
2.6 Microscopy and Data Analysis 
 Photographs were taken using a smartphone camera (iPhone).  Images of statically grown 
biofilms were captured using an EVOS® imaging microscope with both transmitted light 
imaging and GFP/RFP filters.  Images for dynamically grown biofilms were completed using a 
Leica microscope paired with Micro-Manager Open Source Microscopy Software and time-lapse 
photography to detect phenotypic differences between the strains; the Leica microscope was also 
used other general microscopy needs throughout research tenure.   
 Scatterplots and R² values were generated using Excel. In graphs and charts, standard 
deviations were calculated and represented by error bars.  FIJI (Fiji Is Just ImageJ) software was 
used to track the speed of individual cells from time-lapse photography image stacks.  All 
tracking was done manually, for which the potential of error has been accounted for by the 
software. 
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3. Results 
3.1 Crystal Violet Assay 
 The crystal violet assays showed little difference between the mutants and wild-type in 
the amount of biomass produced by the strains.  Figure 11 shows the relationships seen from 
assays conducted on Days 3 and 5 of growth respectively.  
Figure 11: Crystal violet assay results. On both Day 3 and 5 at 570 and 595 nm, no major differences could be 
observed in biomass production between WT PAO1 and mutants. 
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3.2 Static Biofilm Growth - Dishes 
3.2.1 Growth at 37℃ - Varied Media 
 When grown in LB broth, no noticeable differences were initially observed between 
GFP-tagged and non-GFP strains in either wild-type or mutants when grown at 37℃.  On Day 2, 
PA4079 showed signs of more tower formation and live attachment to the edges of the glass 
coverslip, and CMS3858 showed more signs of more motility which led to difficulty in imaging.  
By Day 4, the mutant biofilms expressed a filamentous, thread-like phenotype with this 
experiment trial (Figures 12A and 12B).  Wild-type PAO1 showed a consistent biofilm lawn 
throughout the entire experiment (Figure 12C). 
 
 
 
Figure 12: Static Biofilm Growth Results - LB Broth. All photos were taken under regular transmitted light (left) 
and GFP/RFP fluorescent light (right) A) Day 4 PA4079 biofilm formation. B) Day 4 CMS3858 biofilm formation. 
C) Day 4 wild-type PAO1 biofilm formation. 
 When grown in M9 minimal media supplemented with 2% glucose, small string-like 
structures were observed in the wild-type PAO1 biofilm throughout experiment; filaments were 
finally stained red on Day 5 of the trial (Figure 13A).  Cells in each of the mutant biofilms were 
more “clumped” to form an aggregate-like biofilm, where cells in the wild-type PAO1 biofilm 
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were dispersed normally throughout the entire experiment (Figure 13B).  Days 6 and 7 did not 
show any major differences in biofilm expression, so future experiments using minimal or lower-
strength medias were ended on Day 5 as with LB broth experiments. 
 
 
 
 
Figure 13: Static Biofilm Growth Results - Minimal Media, 37℃. A) Filamentous structure was observed only in 
wild-type biofilm throughout experiment, seen above on Day 1, then on Day 5 stained red. B) Wild-type PAO1 
versus clumping phenotype seen in mutant biofilms. 
3.2.2 Growth at 22℃ - Varied Media  
 Results at 22℃ for both LB broth and supplemented M9 minimal media were similar to 
those seen at 37℃.  In LB broth, both mutants again formed thread-like, wispy biofilms whereas 
the wild-type formed a typical biofilm lawn (Figure 14A).  When grown in minimal media, both 
mutant strains showed the clumping, aggregate phenotype as seen in at 37℃ when compared to 
the wild-type biofilm (Figure 14B, Pg. 25).  These results lead us to believe that the PA4079 gene 
influences phenotypic expression when grown in static conditions. 
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Figure 14: Static Biofilm Growth Results - 22℃. A) Day 4, LB Broth. Wild-type PAO1 consistent biofilm lawn 
compared to thread-like phenotype expressed within both mutant biofilms. B) Day 4, Minimal Media. Wild-type 
PAO1 versus clumping phenotype seen in mutant biofilms. 
3.3 Dynamic Biofilm Growth - Flow Cell System 
 As discussed in Section 2, time-lapse photography was captured daily for each line 
during each experiment, and images were transformed to a stack in which the speed of individual 
cells could be quantified within the biofilms.  Recall the strains used for flow cell system trials 
were wild-type PAO1 and the CMS3858 mutant (clean deletion of PA4079 gene).  Using FIJI, 
individual cells were manually tracked and movement was plotted as distance moved over time 
with Excel.  For quantification purposes, the conversions of 1 pixel = 1 µm were used to track 
the movement of cells within the daily time-lapse videos.  Deviations were calculated by FIJI 
software. 
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 For the trial conducted at 22℃ with full-strength LB broth, visible differences in motility 
were seen beginning on Day 3 and were consistent to Day 5.  It was visible through the time-
lapse videos that CMS3858 cells moved faster than the wild-type cells in biofilms, which was 
calculated to be 2.57 and 5.08, and 1.82 times faster, as shown by the data on Days 3, 4, and 5 
respectively (Figure 15).  For the experiment at 22℃ with 1/10X LB, videos showed that 
CMS3858 cells moved at roughly the same rate as the wild-type; speed was calculated to show 
that CMS3858 is moving 1.06 and 1.10 times faster that the wild-type on Days 3 and 5 
respectively (Figure 16).  Day 4 showed no difference in speed between the wild-type and 
CMS3858. 
 
    
(Continued on Next Page) 
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Figure 15: Speed Graphs for 22℃ and LB.  A) Day 3.  B) Day 4.  C) Day 5. 
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Figure 16: Speed Graphs for 22℃ and 1/10X LB.  A) Day 3.  B) Day 5. 
 For the trial run at 37℃ with full-strength LB broth, similar results were again similar to 
the experiment at 22℃ with full-strength LB.  Figure 17 shows the mutant CMS3858 cells move 
1.64, 1.98, and 2.00 times faster than the wild-type.  A trial at 37℃ for the 1/10X LB broth was 
not conducted at this time due to a leak in the waste container and glass cells.   
 For accurate conclusions of the flow cell system experiments, this experiment will need 
to be completed and data will need to be included. 
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CMS3858 moves 1.06X faster than WT PAO1 (±0.05)
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Figure 17: Speed Graphs for 37℃ and LB.  A) Day 3.  B) Day 4.  C) Day 5. 
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3.4 Pyocyanin Assays 
 No major differences were noticed in amount of pyocyanin produced between wild-type 
PAO1 and the two mutant strains.  This was surprising, as both PA4079 and CMS3858 appeared 
to express more of the blue-green pigment when grown in liquid culture (Figure 10A).  
Experiments to quantify the amount of pyocyanin produced per strain yielded results too similar 
to prove a difference between the wild-type PAO1 and mutant strains exists.  More 
experimentation and different assays need to be conducted to extract pyocyanin from these P. 
aeruginosa strains.  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5. Conclusions and Future Works 
 Our group intends to further study the role of the PA4079 gene and other gene homologs 
in P. aeruginosa to determine which genes control social motility, and how these genes 
ultimately influence phenotypic expression within the formation of biofilms.  Experiments will 
be conducted using strain CMS4293, which is the PA4079 gene complimented strain of 
CMS3858, to show that the PA4079 gene is contributing to the results seen in its absence.  Trials 
using CMS4293 will determine if reintroducing the gene of interest restores wild-type function 
to the CMS3858 clean deletion mutant.  An experiment with the flow cell system using 1/10X 
strength LB broth at 37℃ should also be conducted to confirm inferences regarding growth rates 
and expression within a dynamic growth environment.  
 With the results seen throughout this investigation, it can be said that the PA4079 gene 
and protein homologs do have an influence on social motility and phenotypic expression within 
Pseudomonas aeruginosa biofilms.  Although the presence of the PA4079 gene in wild-type P. 
aeruginosa appears to act as a motility repressor, the mode of inhibition has not been specified so 
further experimentation must be conducted.  Understanding the social motility factors of P. 
aeruginosa as a model organism is promising for the treatment and prevention of infections 
caused by pathogenic biofilms, as seen in cystic fibrosis, wounds, and implants.  Recognizing 
genes and homologs responsible for dispersal from pathogenic biofilms could present a possible 
target for new treatments.  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Appendix 
Table 1A: P. aeruginosa Isolates -  Growth Curve CFU Counts. CFU counts show no significant 
differences in growth rates between all mutant strains at 37℃ temperature in respective medias.   
Table 2A: Tables used to generate chart for Day 3 Crystal Violet Assay.   
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Shanks Strains
0 Hour 24 Hour
CMS4202 1.9x10⁶ 3.7x10⁹
CMS4292 2.1x10⁶ 2.4x10⁹
CMS4293 1.9x10⁶ 2.1x10⁹
CMS3960 2.4x10⁶ 3.3x10⁹
UEGC Strains
0 Hour 24 Hour
(WT) PAO1 1.9x10⁶ 4.2x10⁹
PA4079 3.9x10⁶ 2.7x10⁹
CMS3858 3.0x10⁶ 3.1x10⁹
(WT) PAO1 + 
pMRP9 4.1x10⁶ 5.1x10⁹
PA4079 + pMRP9 3.5x10⁶ 3.2x10⁸
CMS3858 + pMRP9 2.1x10⁶ 2.3x10⁹
Day 3, 570 nm
1 2 3 4 5 6 7
1 1.9424 1.9402 1.8725 2.0937 1.7094 1.1728 1.2802
2 2.1506 1.7917 1.4938 1.5895 1.0428 1.1347 0.9722
3 2.4762 2.0407 1.5821 2.0848 1.4738 1.1726 1.2141
Average 2.189733333333331.9242 1.649466666666671.922 66666666671.408 66666666671.1 0033333333331.1555
SD 0.2690430696623370.1252687111772130.1981341044175220.288 651110812490.3380394257085010.02193953812944420. 621 6446152853
Avg.StDev 0.200448058047017
Day 3, 595 nm
1 2 3 4 5 6 7
1 1.4805 1.4724 1.426 1.5529 1.2945 0.9364 0.9607
2 1.5605 1.3901 1.1616 1.2221 0.8646 0.9111 0.7808
3 1.7866 1.5016 1.1848 1.5095 1.0991 0.9288 0.9256
Average 1.6092 1.4547 1.257466666666671.428166666666671.08 066666666670.9254333333333330.8890 333333333
SD 0.1587547479604940.05781894153303060.1464143890925110.1797734500234490.2152 61459198130.0 298165372105310.095361644980219
Avg.StDev 0.123764424747224
Table 3A: Tables used to generate chart for Day 5 Crystal Violet Assay.   
Table 4A: Data for graphs of trials at 22℃ in LB broth.  
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UWGC Strains Shanks Strains
Day 5, 595 nm
1 2 3 4 5 6 7
1 2.2016 1.9483 1.7971 1.9291 2.0157 2.3528 1.9753
2 1.8801 2.0459 1.7142 2.2379 1.8635 1.3716 1.9214
3 1.9866 1.6347 1.9999 2.135 2.333 1.4481 1.9539
Average 2.022766666666671.8 63 1.837066666666672.100 66666666672.070733333333331.724166666666671.9502
StDev 0.1637729627665490.2148 72946071230.14698 4117624620.1572369019452280.2395392730500230.5457544899800030.0271398231387016
Avg.StDev 0.186909269656261
Day 5, 570 nm
1 2 3 4 5 6 7
1 2.9001 2.5827 2.3415 2.5208 2.5849 3.0519 2.5363
2 2.4757 2.715 2.2706 2.9815 2.4242 1.8188 2.5502
3 2.6508 2.1551 2.6524 2.7549 3.0621 1.8534 2.5598
Average 2.675533333333332.484266666666672.4215 2.7524 2.6904 2.241366666666672.54876666666667
StDev 0.2132783236368230.2926411511276790.2030832587881140.2303601745093970.3317782241196670.7021556119075980.0118153854500533
Avg.StDev 0.283587447077047
Day 3
Time 
(Sec)
WT 
PAO1
WT 
PAO1
CMS
3858
CMS
3858
0 0 0 0 0
0.1 12 9 35 44
0.2 37 31 95 84
0.3 81 79 162 175
0.4 102 95 261 252
0.5 145 136 354 326
0.6 163 158 413 447
0.7 187 183 482 463
0.8 201 210 522 521
0.9 209 216 595 564
Avg 113.7 111.7 291.9 287.6
Avg / 
strain
112.7 289.75
289.75/
112.2 = 
2.57
Day 4
Time 
(Sec)
WT 
PAO1
WT 
PAO1
CMS
3858
CMS
3858
0 0 0 0 0
0.1 13 7 40 36
0.2 19 18 67 117
0.3 35 32 134 140
0.4 46 47 209 188
0.5 53 55 276 231
0.6 67 61 327 286
0.7 73 69 413 344
0.8 81 75 497 388
0.9 89 86 573 441
Avg 47.6 45 253.6 217.1
Avg / 
strain
46.3 235.35
235.35/
46.3 = 
5.08
Day 5
Time 
(Sec)
WT 
PAO1
WT 
PAO1
CMS
3858
CMS
3858
0 0 0 0 0
0.1 35 16 33 26
0.2 51 35 65 54
0.3 56 66 113 94
0.4 93 103 177 175
0.5 139 126 226 221
0.6 158 168 260 335
0.7 172 209 306 369
0.8 183 224 380 414
0.9 209 241 436 470
Avg 109.6 118.8 199.6 215.8
Avg / 
strain
114.2 207.7
207.7/
114.2= 
1.82
Table 5A: Data for graphs of trials at 22℃ in 1/10X LB broth.  
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Day 3
Time 
(Sec)
WT 
PAO1
WT 
PAO1
CMS
3858
CMS
3858
0 0 0 0 0
0.1 7 15 14 12
0.2 23 27 28 25
0.3 38 63 55 41
0.4 66 91 72 54
0.5 117 119 118 69
0.6 135 139 142 122
0.7 150 156 157 154
0.8 173 171 175 172
0.9 194 200 201 202
1.0 237 219 225 221
1.1 261 236 264 260
1.2 281 244 253 304
1.3 297 260 287 326
1.4 307 269 295 348
1.5 323 291 303 358
1.6 337 296 313 402
1.7 343 311 338 413
1.8 362 349 354 424
1.9 375 380 382 449
Avg 201.3 191.8 198.8 217.8
Avg / 
strain
196.55 208.3
208.3/
196.55 
= 1.06
Day 5
Time 
(Sec)
WT 
PAO1
WT
 PAO1
CMS
3858
CMS
3858
0 0 0 0 0
0.1 26 17 3 22
0.2 44 31 25 32
0.3 59 35 32 44
0.4 72 43 42 57
0.5 87 52 52 69
0.6 96 65 75 76
0.7 103 81 92 84
0.8 115 88 104 101
0.9 122 97 116 113
1.0 127 109 128 126
1.1 133 125 134 133
1.2 137 135 142 140
1.3 146 144 151 154
1.4 153 152 159 178
1.5 159 155 170 193
1.6 164 157 185 202
1.7 166 160 197 221
1.8 174 163 208 237
1.9 182 164 222 248
Avg 113.25 98.65 111.85 121.5
Avg / 
strain
105.95 116.675
116.675
/ 
105.95
= 1.10
Table 6A: Data for graphs of trials at 37℃ in LB broth.  
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Day 3
Time 
(Sec)
WT 
PAO1
WT 
PAO1
CMS
3858
CMS
3858
0 0 0 0 0
0.1 9 20 20 7
0.2 20 27 28 24
0.3 36 31 40 38
0.4 50 37 52 49
0.5 66 43 65 71
0.6 82 58 86 97
0.7 102 75 109 118
0.8 121 87 126 131
0.9 133 92 153 154
1.0 144 107 175 182
1.1 152 123 198 216
1.2 160 137 226 244
1.3 163 140 248 273
1.4 171 155 287 302
1.5 181 170 314 325
1.6 188 185 343 351
1.7 194 198 364 373
1.8 202 209 388 402
1.9 217 230 406 434
Avg 119.55 106.2 181.4 189.55
Avg /
strain
112.875 185.475
185.475 / 
112.875
= 1.64
Day 4
Time 
(Sec)
WT 
PAO1
WT 
PAO1
CMS
3858
CMS3
858
0 0 0 0 0
0.1 8 13 48 47
0.2 30 23 95 76
0.3 48 39 128 110
0.4 72 59 153 125
0.5 87 79 175 155
0.6 98 92 205 188
0.7 120 112 247 221
0.8 143 123 279 252
0.9 156 139 302 277
1.0 180 153 337 314
1.1 191 166 364 342
1.2 212 181 391 373
1.3 234 207 434 405
1.4 254 217 471 452
1.5 272 237 515 492
1.6 301 258 549 524
1.7 320 271 588 556
1.8 345 295 620 597
1.9 358 316 653 627
Avg 171.45 149 327.7 306.65
Avg /
strain
160.225 317.175
317.175 /
160.225
= 1.98
Day 5
Time 
(Sec)
WT 
PAO1
WT 
PAO1
CMS
3858
CMS
3858
0 0 0 0 0
0.1 7 1 10 11
0.2 10 9 18 32
0.3 18 14 28 43
0.4 23 23 39 50
0.5 29 25 49 65
0.6 35 32 62 72
0.7 39 35 71 82
0.8 41 43 80 95
0.9 52 48 91 105
1.0 57 54 102 114
1.1 63 57 114 125
1.2 66 67 123 131
1.3 70 73 133 141
1.4 74 79 147 150
1.5 79 85 159 164
1.6 85 92 174 175
1.7 88 100 185 185
1.8 96 105 204 194
1.9 101 112 220 211
Avg 51.65 52.7 100.45 107.25
Avg /
strain
52.175 103.85
103.85 / 
52.175
= 2.00
